Benefits of combining Visionable's virtual platform with Brainomix's e-Stroke imaging already demonstrated at Ipswich HospitalKENT, England and OXFORD, England, Nov. 10, 2022 /PRNewswire/
/PRNewswire/ Brainomix, the AI-powered medtech solutions company, and Bridge Biotherapeutics, Inc., a South Korean clinical-stage biotechnology company.
Brainomix awarded a world-first, nationwide tender for its e-Stroke platform, which will be deployed across all stroke centers in Hungary as part of the National Institute for Health Development